1. Home
  2. KRYS vs HXL Comparison

KRYS vs HXL Comparison

Compare KRYS & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$340.21

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Logo Hexcel Corporation

HXL

Hexcel Corporation

HOLD

Current Price

$96.12

Market Cap

7.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
HXL
Founded
2015
1946
Country
United States
United States
Employees
295
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
7.4B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
KRYS
HXL
Price
$340.21
$96.12
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$297.60
$88.30
AVG Volume (30 Days)
294.7K
857.8K
Earning Date
05-04-2026
04-22-2026
Dividend Yield
N/A
0.80%
EPS Growth
128.00
N/A
EPS
1.83
N/A
Revenue
$389,130,000.00
$1,893,900,000.00
Revenue This Year
$38.74
$10.09
Revenue Next Year
$32.53
$12.33
P/E Ratio
$187.67
N/A
Revenue Growth
33.94
N/A
52 Week Low
$130.50
$56.20
52 Week High
$356.50
$101.51

Technical Indicators

Market Signals
Indicator
KRYS
HXL
Relative Strength Index (RSI) 65.25 56.21
Support Level $253.89 $81.10
Resistance Level N/A $97.69
Average True Range (ATR) 12.77 3.22
MACD 2.68 0.53
Stochastic Oscillator 72.67 62.05

Price Performance

Historical Comparison
KRYS
HXL

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use primarily in the commercial aerospace and defense markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engine nacelles, and other structures and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.

Share on Social Networks: